Nathan Allison, MD
Surgery · Melbourne, FLNPI 1003132887
Payments from drug & device makers
Across 152 payments — averaging $535.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$26K
- Medical Device Business Services, Inc.$23K
- Medtronic$15K
- Covidien LP$13K
- Intuitive Surgical$2K
- W. L. Gore & Associates, Inc.$646
- plus $426 from 13 others
What the payments were for
- Consulting fees$52,80465%
- Speaking & faculty fees$21,20026%
- Travel & lodging$2,2083%
- Food & beverage$4,0325%
- Education$1,1681%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(3 entities) | 29 | $25,817 |
| Medical Device Business Services, Inc. | 8 | $23,351 |
| Medtronic | 39 | $15,369 |
| Covidien LP | 13 | $13,372 |
| Intuitive Surgical | 18 | $2,430 |
| W. L. Gore & Associates, Inc. | 13 | $646 |
| Kvk-tech, Inc. | 13 | $105 |
| Endo Pharmaceuticals Inc. | 5 | $83 |
| Novo Nordisk | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Smith+Nephew | 2 | $30 |
| Avanos Medical | 1 | $21 |
| Shire North American Group Inc | 1 | $19 |
| Davol Inc. | 1 | $17 |
| AbbVie | 1 | $17 |
| Innovation Technologies Inc | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Merck | 1 | $16 |
| KCI USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$81,411 in reported general payments places this provider in the 95th percentile of 1,569 surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 171 | $4,141 |
| Sucralfate | 48 | $1,751 |
| Pantoprazole Sodium | 40 | $818 |
| Ondansetron OdtOndansetron | 41 | $499 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $127 |
| Prednisone | 16 | $17 |
Paid to pharmacies, not to this prescriber.
Other surgery in Melbourne
- Jorge FlorinWinter Garden$2.2M
- Steven FagienBoca Raton$1.6M
- John MullinaxTampa$1.5M
- Amit TaggarTampa$1.4M
- Panagiotis SarantosGainesville$1.3M
- Keith KimCelebration$1.1M
- Christopher DucoinTampa$1.1M
- Andre TeixeiraOcala$1M
- Richard DiciccoTampa$964K
- Salvatore DocimoTampa$950K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.